We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Centene's Gold Card Push Could Ease Costs - But Will Savings Follow?
Read MoreHide Full Article
Key Takeaways
Centene will launch its Gold Card program nationwide in November 2026, initially covering 160,000 providers.
Qualifying providers can bypass prior authorization for eligible outpatient care, reducing routine reviews.
Centene trades at 13.13 times forward earnings, while 2026 EPS is estimated to grow 135.1% to $4.89.
Centene Corporation (CNC - Free Report) is set to launch its National Performance-Based Gold Card Program nationwide in November 2026, aiming to simplify prior authorization for healthcare providers. The program will initially cover more than 160,000 qualifying providers for select outpatient services. The nationwide rollout also provides CNC with a broader framework to standardize authorization practices across its health plans.
Providers that consistently meet clinical review requirements can gain Gold Card status, allowing them to submit pre-notifications and proceed with eligible outpatient services without waiting for prior authorization decisions. Eligibility will depend on approval history, documentation quality, compliance with medical policy and applicable regulatory requirements.
The move matters because prior authorization can create administrative work for both healthcare providers and insurers. Offering qualifying providers a faster approval pathway could reduce routine review requirements while preserving clinical oversight. Streamlined interactions with providers could also enhance the experience for members and healthcare partners while simplifying authorization workflows.
Fewer administrative reviews could help Centene lower processing costs and improve operating efficiency over time. The initiative could strengthen provider relationships and enhance the member experience. However, the financial benefits will depend on provider adoption, realized administrative savings and the company's ability to maintain effective medical utilization controls. Successful implementation may support Centene's long-term cost structure and operating performance, although the extent of any earnings contribution remains uncertain.
How Are Competitors Faring?
Some of CNC’s major competitors in the managed-care space are UnitedHealth Group Incorporated (UNH - Free Report) and Elevance Health, Inc. (ELV - Free Report) .
UnitedHealth is simplifying provider workflows through UnitedHealthcare's move to eliminate 30% of prior authorization requirements, with the changes set to take effect in October 2026. UNH’s national Gold Card program also reduces authorization requirements for qualifying provider groups, supporting administrative efficiency.
Elevance Health is using its Health OS platform and electronic prior authorization tools to streamline clinical reviews. Through April 2026, more than 250,000 electronic medical prior authorization requests were processed, with more than 42% of decisions completed in one minute or less, helping ELV reduce administrative delays.
Shares of CNC have gained 67.4% in the year-to-date period compared with the industry’s growth of 18.7%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 13.13, below the industry average of 15.41. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $4.89 per share, implying 135.1% growth from the year-ago period’s level.
View the Zacks #1 Rank List
Image: Bigstock
Centene's Gold Card Push Could Ease Costs - But Will Savings Follow?
Key Takeaways
Centene Corporation (CNC - Free Report) is set to launch its National Performance-Based Gold Card Program nationwide in November 2026, aiming to simplify prior authorization for healthcare providers. The program will initially cover more than 160,000 qualifying providers for select outpatient services. The nationwide rollout also provides CNC with a broader framework to standardize authorization practices across its health plans.
Providers that consistently meet clinical review requirements can gain Gold Card status, allowing them to submit pre-notifications and proceed with eligible outpatient services without waiting for prior authorization decisions. Eligibility will depend on approval history, documentation quality, compliance with medical policy and applicable regulatory requirements.
The move matters because prior authorization can create administrative work for both healthcare providers and insurers. Offering qualifying providers a faster approval pathway could reduce routine review requirements while preserving clinical oversight. Streamlined interactions with providers could also enhance the experience for members and healthcare partners while simplifying authorization workflows.
Fewer administrative reviews could help Centene lower processing costs and improve operating efficiency over time. The initiative could strengthen provider relationships and enhance the member experience. However, the financial benefits will depend on provider adoption, realized administrative savings and the company's ability to maintain effective medical utilization controls. Successful implementation may support Centene's long-term cost structure and operating performance, although the extent of any earnings contribution remains uncertain.
How Are Competitors Faring?
Some of CNC’s major competitors in the managed-care space are UnitedHealth Group Incorporated (UNH - Free Report) and Elevance Health, Inc. (ELV - Free Report) .
UnitedHealth is simplifying provider workflows through UnitedHealthcare's move to eliminate 30% of prior authorization requirements, with the changes set to take effect in October 2026. UNH’s national Gold Card program also reduces authorization requirements for qualifying provider groups, supporting administrative efficiency.
Elevance Health is using its Health OS platform and electronic prior authorization tools to streamline clinical reviews. Through April 2026, more than 250,000 electronic medical prior authorization requests were processed, with more than 42% of decisions completed in one minute or less, helping ELV reduce administrative delays.
Centene’s Price Performance, Valuation & Estimates
Shares of CNC have gained 67.4% in the year-to-date period compared with the industry’s growth of 18.7%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 13.13, below the industry average of 15.41. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $4.89 per share, implying 135.1% growth from the year-ago period’s level.
Image Source: Zacks Investment Research
CNC stock currently has a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.